Product Information
LABETALOL HCL 300 MG TABLET is a generic product labeled by Eywa Pharma Inc, priced at $0.2046 per EA under NDC 71930003712. Its NADAC has been published 357 times since Jul 24, 2019.
Strength
300 mg/1
Manufacturer
Eywa Pharma IncNDC
71930003712
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
LABETALOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207863On Market Since
5/24/2019
Pharmacological Classes
Price Statistics
The NADAC for LABETALOL HCL 300 MG TABLET has been published 357 times since Jul 24, 2019, and over the history we have for it it has declined 28.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2046 per EA |
|---|---|
| All-time high | $0.3238 (Jun 10, 2020) |
| All-time low | $0.1776 (Nov 20, 2024) |
| 52-week high | $0.2117 |
| 52-week low | $0.1998 |
| Median price | $0.2166 |
| Average price | $0.2304 |
| Largest weekly change | +21.9% (Feb 17, 2021) |
| Weeks tracked | 357 |
| Tracking since | Jul 24, 2019 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LABETALOL HCL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 300 MG TABLET, manufactured by Eywa Pharma Inc, is $0.2046 per EA (NDC 71930003712), effective May 20, 2026.
How has the price of LABETALOL HCL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LABETALOL HCL 300 MG TABLET has declined 28.6%. It has been tracked across 357 weekly CMS publications since Jul 24, 2019.
What are the highest and lowest recorded NADAC prices for LABETALOL HCL 300 MG TABLET?
Since Jul 24, 2019, the NADAC for LABETALOL HCL 300 MG TABLET has ranged from a low of $0.1776 (Nov 20, 2024) to a high of $0.3238 (Jun 10, 2020), with a median of $0.2166 per EA.
Are there cheaper alternatives to LABETALOL HCL 300 MG TABLET?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LABETALOL HCL 300 MG TABLET, is $0.2041 per EA — about 0% below LABETALOL HCL 300 MG TABLET.
Who manufactures LABETALOL HCL 300 MG TABLET?
LABETALOL HCL 300 MG TABLET (NDC 71930003712) is labeled by Eywa Pharma Inc, and CMS classifies it as a generic product.
Related Drugs
Same classification